Email not displaying correctly? View it in your browser.

Photo of Senator Joan Hartley.


Joan Hartley

An Independent Voice

Cutting the Ribbon on the Future of Bioscience in Connecticut

This week I joined several of my colleagues in the General Assembly along with some of Connecticut's leading minds in the field of bioscience and precision medicine to cut the ribbon on Yale's new Center for Genome Analysis. Yale believes that this new Center will be vital in realizing the potential of personalized medicine in treating cancer and newborn diseases.

Senator Hartley at ribbon cutting.

In addition to furthering our ability to treat disease, this center will also be an important economic engine in Connecticut, where the bioscience and precision medicine business sector is growing rapidly. The new Center for Genome Analysis will add to the pipeline of discoveries and inventions made at Yale and developed by the private sector. In the past year, Yale received about 240 invention disclosures from faculty and filed over 400 patent applications. Over the past 20 years, Yale inventions have led to nearly 60 companies in the New Haven region that have attracted more than $1 billion of professional venture capital investment and have created over 1,400 jobs in the region. There are currently six Yale drugs on the market and another 40 in pre-clinical or human testing. There are an additional five devices or diagnostic tests in the market, and another 15 in development or testing. The Center for Genome Analysis is expected to contribute to even more business development and job growth.